Canine Hemangiosarcoma Spleen Treatment

🧫

Thanks for reaching out about this challenging case. A post-splenectomy hemangiosarcoma diagnosis is always tough, and it's good you're moving quickly to discuss adjuvant therapy.

Here is the standard-of-care approach and my thoughts on the questions you raised.

1. Doxorubicin Protocol
The recommended protocol is single-agent doxorubicin.
* Dose: 30 mg/m² IV administered slowly over 20-30 minutes.
* Frequency: Every 3 weeks for a total of 5-6 cycles.
* Key Precaution: Given that the patient is a German Shepherd, a breed predisposed to dilated cardiomyopathy (DCM), a pre-treatment echocardiogram is absolutely critical to assess baseline cardiac function. We must ensure the patient can tolerate the potential cardiotoxic effects of doxorubicin. We track the cumulative dose, aiming to stay below 180 mg/m².

2. Expected Survival Times
This is a diagnosis where chemotherapy provides a clear, albeit modest, survival benefit. It's crucial to frame this for the owner in terms of quality of life.
* Splenectomy alone: Median survival time (MST) is unfortunately only 1-3 months.
* Splenectomy + Doxorubicin: MST increases to approximately 5-7 months, with about 10-15% of dogs making it to one year.

The goal of chemotherapy here is not a cure, but to delay metastasis and provide several months of good quality life. Most dogs tolerate the protocol well and feel excellent between treatments.

3. I'm-Yunity (Coriolus Versicolor) Supplement
I am very familiar with the Penn study that brought this supplement to prominence. While the results were intriguing, we must be cautious. It was a small, non-randomized, unblinded pilot study, and the impressive survival times reported have not been replicated in larger, controlled trials.

My position is this: it is not a replacement for doxorubicin, which remains the standard of care with proven efficacy. If an owner is interested in using it as an adjunct alongside chemotherapy, I don't object, as it appears to be safe with minimal side effects. However, I am honest that its benefit is unproven and it should not be used in place of conventional treatment.

In summary, the best plan is to proceed with a baseline echo and, if clear, begin the doxorubicin protocol. This gives your patient the best chance at extending a good quality of life.

Let me know if you want to spawn a Chemo Protocol Calculator (onc-chemo) for a precise BSA calculation and dosing schedule for this patient.

— Dr. Rachel Torres